PerkinElmer Announces Acquisition of Geospiza
News May 16, 2011
The addition of Geospiza to PerkinElmer’s sequencing and analysis services will deliver an end-to-end solution that provides scientists access to sequencing services and robust analysis and visualization software, offered through significant capability around cloud computing. This solution enables “anytime, anywhere” genomic data interpretation and analysis, all backed by PerkinElmer expertise and the highest quality standards.
“Genomic information is becoming increasingly important in understanding and treating disease. Making sense of the unprecedented volumes of data generated by next generation sequencing and other biological measurements is critical to improve the disease diagnosis process and drug discovery,” said Richard Begley, PhD, president, Emerging Technologies, PerkinElmer.
He added, “The acquisition of Geospiza, along with existing software in our various diagnostic businesses, gives PerkinElmer a strong platform for offerings in nucleic acid testing. Geospiza is a leader in its industry, and a strong addition to PerkinElmer’s bioinformatics capabilities. We look forward to expanding our family of genetic analysis offerings in research, drug discovery and diagnostics.”
Geospiza’s clients include biotechnology and pharmaceutical companies, universities, researchers, contract core and diagnostic service laboratories involved in genetic testing and manufacturing biotherapeutics.
Geospiza’s current informatics offerings include:
• GeneSifter™ Analysis Edition – a cloud-based data analysis product for microarray and next generation sequencing data. GeneSifter Analysis Edition helps biologists readily incorporate sophisticated data management and computational analysis into their research efforts. The results include improved quality and productivity in the experimental and decision-making processes. This product is a valuable tool for interpreting the vast amounts of genetic data produced by Microarray and Next Generation Sequencing technologies and supports all of the major sequencing and array platforms.
• GeneSifter™ Lab Edition – Geospiza’s software platform supporting laboratory workflows. This out-of-the-box lab management system with intelligent workflows helps researchers get started immediately, and has flexibility to adapt to specific needs without custom programming. Genesifter Lab Edition significantly increases capacity, reduces backlog, eliminates errors due to manual processes, and speeds time to discovery in user labs.
Computer bits are binary, with a value of 0 or 1. By contrast, neurons in the brain can have all kinds of different internal states, depending on the input that they received. This allows the brain to process information in a more energy-efficient manner than a computer. A new study hopes to bring the two closer together.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019